Stable Angina : News
Print
Email
SaveHealthline's Premium Tools
Healthline Part D Plan Selector
Medicare's drug plans are subsidized by the US federal government and offered through insurers.
Advertisement
Marketplace
|
' The COURAGE trial compared the effect of percutaneous coronary intervention plus optimal medical therapy with optimal medical therapy alone on cardiovascular events in 2287 patients with stable coronary ...
|
|
... Article Date: 25 Sep 2008 - 6:00 PDT A landmark study indicating that angioplasty may not be cost effective for some stable heart disease patients and research indicating individualized consent forms may help patients make better decisions are among ...
|
|
... development program and include the potential to also utilize varespladib as an adjunctive treatment in patients with stable coronary disease and elevated levels of LDL-C and total cholesterol. "We are pleased that both agencies recognized the ...
|
|
While U.S. label expansion efforts continue, CV Therapeutics Inc. granted ex-U.S. marketing rights for angina drug Ranexa to Menarini Group, of Florence, Italy.
|
|
Drug therapy may be as effective as angioplasty, above, or other invasive interventions used to manage angina, new research suggests.
|
|
... as well as stress," she said. The study's 48 participants had been hospitalized for either a heart attack, unstable angina or worsening symptoms of stable coronary artery disease. Their median age was 57 years, 81 percent were male, 40 percent had ...
|
|
... B-cell NHL in combination with CVP chemotherapy. Rituxan is indicated for the treatment of nonprogressing (including stable disease), low-grade, CD20positive, B-cell NHL, as a single agent, following first-line treatment with CVP chemotherapy. ...
|
|
... injection catheter. Subjects must be between 25 and 75 years of age with at least a 3 month history of chronic stable angina triggered by physical exertion and must have a Canadian Cardiovascular Society (CCS) anginal classification III or IV while ...
|
|
... them up to a monitor for 24-hour stretches. The participants had all been hospitalized for a heart attack, unstable angina, or worsening symptoms of stable coronary artery disease, and had all undergone angioplasty or stent implantation. Most were ...
|
|
... clopidogrel, based upon a point-of-care assay, who underwent elective coronary angioplasty at ten European sites for stable or low-risk unstable coronary artery disease. Patients were randomly assigned in a double blind manner to receive either ...
|
|
... from 'door to balloon' after all. Three-quarters of all patients who undergo angioplasty and stenting have 'chronic stable heart angina' and may not need such procedures immediately if ever. Drug treatment may be just as effective, according to ...
|
 |
 |
Home | About | Health Experts | Careers | Site Map | Feedback | Help | Health Tools | Tell a Friend
Advertise | Terms of Use | Privacy Policy
Advertise | Terms of Use | Privacy Policy
Copyright © 2005 - 2008 Healthline Networks, Inc. All rights reserved.